| Literature DB >> 32179781 |
Domnic Colvin1, Vishnu Dhuri1, Hirday Verma2, Rama Lokhande2, Avinash Kale3.
Abstract
Various bacteria from the Bacillus species have been used as pesticides against mosquito larvae for more than a decade. The prolonged use of these bacterial species by little alteration within their genome, using various permutations and combinations of mosquito-cidal toxins, has proven unsuccessful in controlling the mosquito population. In our current study we report Enterococcus sp. to be exhibiting similar kind of mosquito-cidal toxins alike those which are present in the mainly used Bacillus strains. Three Enterococcus species were isolated on a rich media selective for gram- positive bacteria from the mid-gut of dead mosquito larvae which were collected from the wild locations within and around the city of Mumbai, India. Their surface morphologies were studied by Scanning Electron Microscopy (SEM) and their identity was confirmed using the standard 16S rRNA sequencing method. Upon performing several repetitive toxicity assays of these three strains on the laboratory cultured third instar stage of Culex quinquefasciatus larvae, showed differential toxicities from a minimum of 20% (LC50: 59.6 CFU/ml), intermediate 35% (LC50: 48.4 CFU/ml) and a maximum of 60% (LC50: 35.7 CFU/ml). To justify the data in all the three similar strains of Enterococcus durans, we followed the differential proteomics using LCMS 6540 UHD Accurate Mass QTOF and differential metabolomics approach using both LCMS 6540 UHD Accurate Mass QTOF and 1H-NMR. The presence and significance of the obtained toxins were studied to elucidate the plausible reason for showing differential toxicities. This work helped in identifying Enterococcus durans as a new, potential and alternative strain to the Bacillus species in terms of mosquito larvicidal toxicity against Culex quinquefasciatus.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32179781 PMCID: PMC7075886 DOI: 10.1038/s41598-020-61245-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Larvicidal toxicity of Enterococcus durans against third instar stage of Culex quinquefasciatus mosquito larvae.
| Strain No. | % Toxicity | Larva (CFU/ml) | 95% Fiducial Limit | Χ2 (d | |
|---|---|---|---|---|---|
| LC50 | LFL | UFL | |||
| S1 | 60% | 35.7 | 25.5 | 59.5 | 2.6 |
| S2 | 35% | 48.4 | 33.9 | 119.3 | 1.75 |
| S3 | 20% | 59.6 | 39.7 | 573.9 | 2.6 |
Control-Nil mortality, LFL = Lower Fiducial Limit, UFL = Upper Fiducial Limit, Χ2 –Chi-square value, df - degrees of freedom, CFU – colony forming units.
Identification of the Enterococcus species using 16S rRNA sequencing and comparing against NCBI database.
| Toxicity | Description | Strain | Max score | Total score | Query cover | E- value | Identity | ||
|---|---|---|---|---|---|---|---|---|---|
| Strain no. 3 | S3 | 20% | JCM 8725 | 1707 | 2853 | 94% | 0.0 | 98% | |
| NBRC 100479 | 1707 | 2857 | 94% | 0.0 | 98% | ||||
| 98D | 1707 | 2892 | 95% | 0.0 | 98% | ||||
| Strain no. 2 | S2 | 35% | JCM 8725 | 1485 | 2753 | 94% | 0.0 | 96% | |
| NBRC 100479 | 1485 | 2757 | 94% | 0.0 | 96% | ||||
| 98D | 1485 | 2757 | 94% | 0.0 | 96% | ||||
| Strain no.1 | S1 | 60% | JCM 8725 | 1633 | 2886 | 98% | 0.0 | 96% | |
| NBRC 100479 | 1633 | 2890 | 98% | 0.0 | 96% | ||||
| 98D | 1633 | 2919 | 99% | 0.0 | 96% | ||||
Enterococcus durans strain JCM8725. NCBI Accession number: NR_113257.
Enterococcus durans strain NBRC 100479. NCBI Accession number: AB681177.
Enterococcus durans strain 98D. NCBI Accession number: NR_036922.
Figure 1The SEM images of identified bacteria: (a) strain 1 (S1); (b) strain 2 (S2); and (c) strain 3 (S3) using ZEISS Ultra-field Emission SEM.
Figure 2Distribution of the housekeeping proteins identified searching LCMS data against the available NCBI database for three strains (S1; S2; and S3) of E. durans.
The results of all mosquito-cidal toxins obtained from LCMS after comparing it with the customized database which had all toxin template sequences of Cry (Cry1 to Cry73), Bin (BinA and BinB) VIP (VIP-1, VIP-2, VIP-3, and VIP-4), and Mtx (Mtx1, Mtx2, Mtx3).
| S1 (Toxicity-60%) | S2 (Toxicity-35%) | S3 (Toxicity-20%) |
|---|---|---|
| Bin-A | ||
| Bin-B | ||
| Cry 9Bb | ||
| Cry 14Aa | ||
| Cry 19Ba/Ca | ||
| Cry 24Ba/Ca | ||
| Cry 25Aa | ||
| Cry 30Da/Ea | Cry 30Da/Ea | |
| Cry 32Aa/Ba/Da | ||
| Cry 33Aa | Cry 33Aa | |
| Cry 35Aa | ||
| Cry 38Aa | ||
| Cry 39Aa | Cry 39Aa | |
| Cry 41Ab | ||
| Cry 48Ab | Cry 42Aa | |
| Cry 45Aa | ||
| Cry 47Aa | ||
| Cry 49Ab | Cry 49Ab | |
| Cry 51Aa | Cry 51Aa | |
| Cry 52Ba | ||
| Cry 53Aa | ||
| Cry 54Aa | ||
| Cry 56Aa | Cry 56Aa | |
| Cry 57Aa | Cry 57Aa | |
| Cry 63Aa | ||
| Cry 64Aa | ||
| Cry 70Bb | ||
| Mtx-2 | ||
| VIP-2 | ||
| VIP-4 |
Figure 3The NMR spectra of the extracted metabolites obtained from Bruker 800 MHz AVANCE-NEO (Topspin 4.01).
Figure 4The MTT Assay of the extracted proteins showing % cell viability of L-929 cell lines.
Figure 5The MTT Assay of the extracted metabolites showing % cell viability of L-929 cell lines.